1. Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma
   Abudureyimu Tuerhong et al, 2021, Cellular and Molecular Life Sciences CrossRef
2. A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models
   Chrysi Xintaropoulou et al, 2015, Oncotarget CrossRef
3. Low-dose 2-deoxyglucose and metformin synergically inhibit proliferation of human polycystic kidney cells by modulating glucose metabolism
   Jing Zhao et al, 2019, Cell Death Discovery CrossRef
4. Emerging Anti-cancer Targets in Mitochondria
   Petr Ježek et al, 2014, Mitochondria: The Anti- cancer Target for the Third Millennium CrossRef
5. Astrocyte Elevated Gene-1 Mediates Glycolysis and Tumorigenesis in Colorectal Carcinoma CellsviaAMPK Signaling
   Hong-tao Song et al, 2014, Mediators of Inflammation CrossRef
6. Insulin and hypoxia-inducible factor-1 cooperate in pancreatic cancer cells to increase cell viability
   DAPENG ZHANG et al, 2015, Oncology Letters CrossRef
7. Modulation of cell physiology under hypoxia in pancreatic cancer
   Matias Estaras et al, 2021, World Journal of Gastroenterology CrossRef
8. The Warburg effect in human pancreatic cancer cells triggers cachexia in athymic mice carrying the cancer cells
   Feng Wang et al, 2018, BMC Cancer CrossRef
9. Targeting glycolysis by 3-bromopyruvate improves tamoxifen cytotoxicity of breast cancer cell lines
   Yasmin M. Attia et al, 2015, BMC Cancer CrossRef
10. Glycolytic inhibitors 2-deoxyglucose and 3-bromopyruvate synergize with photodynamic therapy respectively to inhibit cell migration
    Xiaolan Feng et al, 2015, Journal of Bioenergetics and Biomembranes CrossRef
11. AMP‐activated protein kinase couples 3‐bromopyruvate‐induced energy depletion to apoptosis via activation of FoxO3a and upregulation of proapoptotic Bcl‐2 proteins
    Cagri Bodur et al, 2016, Molecular Carcinogenesis CrossRef
12. Metabolism addiction in pancreatic cancer
    R Blum et al, 2014, Cell Death & Disease CrossRef
13. Glucose metabolic phenotype of pancreatic cancer
    Anthony KC Chan et al, 2016, World Journal of Gastroenterology CrossRef
14. Intra-Pancreatic Insulin Nourishes Cancer Cells: Do Insulin-Receptor Antagonists such as PGG and EGCG Play a Role?
    Lijuan Hu et al, 2020, The American Journal of Chinese Medicine CrossRef
15. The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside
    J. Azevedo-Silva et al, 2016, Journal of Bioenergetics and Biomembranes CrossRef
16. Poly(lactic-co-glycolic) Acid Nanoparticles Localize in Vesicles After Diffusing into Cells and are Retained by Intracellular Traffic Modulators
    Neha Singh et al, 2023, Nanomedicine CrossRef
17. Four types of fatty acids exert differential impact on pancreatic cancer growth
    Ming Yu et al, 2015, Cancer Letters CrossRef
18. Low glucose availability stimulates progesterone production by mouse ovariesin vitro
    Kathryn Wilsterman et al, 2017, Journal of Experimental Biology CrossRef
19. Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment
    Tengjiao Fan et al, 2019, Cancers CrossRef
20. Combination of 2-deoxy d-glucose and metformin for synergistic inhibition of non-small cell lung cancer: A reactive oxygen species and P-p38 mediated mechanism
    Xiao-bin Hou et al, 2016, Biomedicine & Pharmacotherapy CrossRef
21. Metabolic reprogramming as a novel therapeutic target for Coxsackievirus B3
    Myeong Uk Kuk et al, 2022, Animal Cells and Systems CrossRef
22. Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer
    Julius Chapiro et al, 2014, Clinical Cancer Research CrossRef
23. Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistance
    Ting-Wan Kao et al, 2023, Journal of Experimental & Clinical Cancer Research CrossRef
24. The Warburg effect drives cachectic states in patients with pancreatobiliary adenocarcinoma
    Qiuju Li et al, 2023, The FASEB Journal CrossRef